E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/19/2019 in the Prospect News Investment Grade Daily and Prospect News Liability Management Daily.

Abbott redeems all $2.85 billion 2.9% notes due 2021 at 101.972

By Wendy Van Sickle

Columbus, Ohio, Dec. 19 – Abbott Laboratories redeemed all $2.85 billion of its 2.9% notes due 2021 on Thursday, according to an 8-K filing with the Securities and Exchange Commission.

The notes were redeemed at 101.972 plus accrued interest to but excluding the redemption date.

Abbott is a pharmaceutical health care products company based in Abbott Park, Ill.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.